Spanish Private Equity Fund enzyme SMEs have increased $ 160 million to digitalize and integrate

NzymeA Spanish private equity fund, technology and sector -backed, has announced its final completion for the Spanish companies operated in the highly fragmented B2B sector by focusing on the traditional business that is likely to have a strong transformation through consolidation.

The fund has attracted the support of CDTI through its SICC Invier, as well as Spanish business families, successful entrepreneurs who have identified the funds of funds, banks and Spain with international family offices.

VescaseManaging Director in EnzyME says: “The successful completion of this fund, in a challenging environment, ensures investors’ confidence in the possibility of the NZEME team, our strategy and the possibility of the transformation and development of Spanish SMEs. We are sure that by combining business unification with technical innovation, we can create a powerful leader in the Traditional and fragmented sector.

“We are committed to a close, hand-on approach to the country’s economic development to generate sustainable prices and through strategic investment and the organization.”

The enzymE is the capital’s capital fund of the latest initiative launched by the Kibo Venture, including the mission to catalyze the transformation of companies and industries that invest. Kibo Ventures It was established by a VC firm in 2002 to address the significant challenges of innovative European technology entrepreneurs and to achieve growth by creating global companies.

The enzymE is prioritized in services and software companies in fragmented industries, which characterize by the possibility of generating their value through sustainability and technology.

Further, the management team is composed of professionals with private equity, technology and business transformation experiences, including Fernando D, Vuggee Baja in Visent, Jose Manuel Gagazla, John Lapez Santamaria and Pablo Campos, children’s network.

Furthermore, there is Oliver Wyman as a strategic adviser to the fund, which allows NZIm to access enhanced sector ownership opportunities, access the channel ownership opportunities and access the company in its portfolio to facilitate internationalization.

Funds have already invested its first, including significant entrance to healthcare distribution, consolidated in the Kuma Group, as well as several investments in professional service agencies. These transactions are part of the strategic project of the EnzyME to create industrial leaders through consolidation and technical innovation in fragmented sectors.

Also, there are advanced plans to integrate other funds of the fund that will strengthen its portfolio growth.

By April 2021, the NZ Kumar completed the division of the Dental Division, re -ensuring that less than two years of acquisition, re -ensuring the ability to make value through active conversion and growth techniques.

Funds explain that they invest in “Concentrates on a cute and hand-on, tightened structured well-directed organizations, supports them in the process of expanding“. Funds give priority to close cooperation with founders and governing parties for the facility of institutionalization, generation shift and internationalization.

The purpose is to support companies that have proven their value in their local markets, many of them are located outside the city center, scaling up, professionalization and effective technology. In this process, the fund provides the basic support of one of the most complex challenges of business growth: transfer of more than 150 people from the structure of the employee, including scalbleable processes, integrated technology and international ambitions.

Starts from about $ 1 million or about 20 employees as the starting point of creating sector platforms aimed at companies with the EnzyME EBITDA. The fund expects a portfolio of 8 to 10 platforms, with the acquisition and consolidation of multiple companies, invested separately between $ 15 to 20 million.

The strategy combines inorganic growth with advanced technology such as AI, Big Data, Machine Learning, IoT, Edge Computing and Cloud to drive to operational skills, scalability and competitive differences.

With an active approach, the fund integrates the technology as the Classic Private Equity Lever – Inheritance, Institutional and International Extension – Sustainable Growth and Manufacturers.



[publish_date

Leave a Reply

Your email address will not be published. Required fields are marked *